Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Balasch, J.
space
  arrow  Vanrell, J. A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Neurohormonal and Hemodynamic Changes in Severe Cases of the Ovarian Hyperstimulation Syndrome

right arrow Juan Balasch, MD; Vicente Arroyo, MD; Francisco Fabregues, MD; Juan Salo, MD; Wladimiro Jimenez, PhD; Juan C. Pare, MD; and Juan A. Vanrell, MD

1 July 1994 | Volume 121 Issue 1 | Pages 27-33

Objective: To evaluate systemic hemodynamics, endogenous vasoactive neurohormonal factors (renin-angiotensin and sympathetic nervous systems, antidiuretic hormone, atrial natriuretic factor, and renal prostaglandins), and renal function in the severe ovarian hyperstimulation syndrome.

Design: Prospective longitudinal study.

Setting: Assisted-reproduction unit of a tertiary care hospital in Barcelona, Spain.

Patients: 31 consecutive patients having in vitro fertilization with development of ascites because of severe ovarian hyperstimulation syndrome.

Measurements: Mean arterial pressure; cardiac output; peripheral vascular resistance; hematocrit concentration; renal function; plasma renin activity; plasma aldosterone, norepinephrine, antidiuretic hormone, and atrial natriuretic peptide determinations; and urinary excretion of prostaglandin E2 and 6-keto-prostaglandin-F1 were measured during the syndrome and 4 to 5 weeks after recovery (baseline).

Results: During the syndrome, patients showed increased hematocrits (mean of the paired difference, 0.047; 95% CI, 0.029 to 0.064), decreased mean arterial pressure ( –16.6 mm Hg; CI, –19.8 to –13.6),increased cardiac output (2.6 L/min; CI, 2.13 to 3.17), and reduced peripheral vascular resistance ( –709 dyne/s · cm–5; CI, –792 to –627).This was accompanied by marked increases of plasma renin (14.4 ng/L · s; CI, 9.87 to 18.90), norepinephrine (1.857 nmol/L; CI, 0.533 to 3.161), antidiuretic hormone (3.3 pg/mL; CI, 1.89 to 4.71), and atrial natriuretic peptide levels (9.7 fmol/mL; CI, 6.1 to 13.2). Hemoconcentration developed in 16 patients (mean of the paired difference in hematocrit concentration, 0.082; CI, 0.063 to 0.101) but not in 15 others (0.009; CI, 0.003 to 0.021). Both groups showed similar values for arterial pressure, cardiac output, and peripheral vascular resistance, but patients with hemoconcentration had higher (P < 0.05) levels of renin (mean, 20.97 ng/L · s (CI, 13.3 to 28.63) compared with 7.83 ng/L · s [CI, 4.08 to 11.58]), norepinephrine (3.907 nmol/L [CI, 3.057 to 4.757] compared with 2.417 [CI, 2.035 to 2.799]), and antidiuretic hormone (6.0 pg/mL [CI, 4.1 to 7.9] compared with 2.4 [CI, 1.7 to 3.03]).

Conclusions: In addition to increased capillary permeability, severe ovarian hyperstimulation syndrome is consistently associated with arteriolar vasodilation. The simultaneous occurrence of these disorders leads to hyperdynamic circulatory dysfunction with marked stimulation of the sympathetic nervous system, renin-angiotensin system, and antidiuretic hormone.

Author and Article Information
space

From Hospital Clinic i Provincial, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Requests for Reprints: Juan Balasch, MD, Department of Obstetrics and Gynecology, Hospital Clinic i Provincial, Casanova 143, 08036 Barcelona, Spain.
Grant Support: In part by a grant from the Direccion General de Investigacion Cientifica y Tecnica (DGICYT PM91-0216). Dr. Fabregues received a grant from the Hospital Clnic i Provincial. Dr. Salo is supported by Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS 93/0610).




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
R. Gomez, C. Simon, J. Remohi, and A. Pellicer
Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability
Biol Reprod, June 1, 2003; 68(6): 2164 - 2171.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Manau, J. Balasch, V. Arroyo, W. Jiménez, F. Fábregues, R. Casamitjana, M. Creus, and J. A. Vanrell
Circulatory Dysfunction in Asymptomatic in Vitro Fertilization Patients. Relationship with Hyperestrogenemia and Activity of Endogenous Vasodilators
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1489 - 1493.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Itskovitz-Eldor, S. Kol, N. Lewit, and J. E. Sealey
Ovarian Origin of Plasma and Peritoneal Fluid Prorenin in Early Pregnancy and in Patients with Ovarian Hyperstimulation Syndrome
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 461 - 464.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1994 by the American College of Physicians.